Blog
BPC-157: Research Overview
BPC-157 is a synthetic pentadecapeptide corresponding to a partial sequence of body protection compound (BPC), originally identified in human gastric juice, studied in animal models of gastrointestinal mucosal and musculoskeletal tissue research.
A rat study of experimentally induced acute and chronic gastric ulcers examined intragastric and intramuscular administration of BPC-157; both routes reduced ulcer area and accelerated healing, with intramuscular administration at 800 ng/kg producing ulcer-formation inhibition rates comparable to or exceeding the reference compound famotidine, and continuous treatment was associated with accelerated rebuilding of glandular epithelium and granulation tissue in chronic ulcers (PubMed).
A separate study using rat Achilles tendon explants and cultured tendon fibroblasts reported that BPC-157 accelerated tendon-explant outgrowth, increased fibroblast survival under oxidative stress, and dose-dependently enhanced fibroblast migration and spreading, with signaling changes consistent with involvement of the FAK–paxillin pathway (PubMed).
For laboratory research use only — not for human consumption. This content is presented for educational and informational purposes and is not intended as medical advice, a treatment claim, or usage instruction.
3 thoughts on “BPC-157: Research Overview”